drug
carvedilol phosphate ER
Marketedupdated 3mo agoby Waylis Therapeutics LLC
Approvedcommunity read0 votes
indications
investigational
Hypertension
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookpatents (8)
- Mar 11, 2026patentUS 8101209*PED
- Mar 11, 2026patentUS 8101209*PED
- Mar 11, 2026patentUS 8101209*PED
- Mar 11, 2026patentUS 8101209*PED
- Sep 11, 2025formulationUS 8101209
- Sep 11, 2025formulationUS 8101209
- Sep 11, 2025formulationUS 8101209
- Sep 11, 2025formulationUS 8101209
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that